Andreas Harstrick
Chief Executive Officer at AFFIMED N.V.
Net worth: 371 085 $ as of 29/04/2024
Network origin in Andreas Harstrick first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ.
34
| Subsidiary | Biotechnology | 34 |
University of Hannover
24
| College/University | Other Consumer Services | 24 |
18
| Public Company | Biotechnology | 18 |
| Public Company | Biotechnology | 8 | |
Merck Serono Ltd.
 Merck Serono Ltd. Miscellaneous Commercial ServicesCommercial Services Merck Serono Ltd. provides research and development services and manufactures medicinal drugs. The company is headquartered in Middlesex, the United Kingdom.
2
| Subsidiary | Miscellaneous Commercial Services | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Andreas Harstrick via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Affimed GmbH
 Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Part of Affimed NV, Affimed GmbH is a clinical leader in innate immuno-oncology. The company, based in Heidelberg, Germany, develops proprietary cancer-targeting bispecific antibodies that activate the innate immune system to kill tumor cells. Affimed leads clinical development of innate cell engagers for solid/hematologic tumors as monotherapy, in combination with NK cells or with checkpoint inhibitors. Adolf Hoess has been the CEO of the German company since 2010. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Chairman Director/Board Member Director/Board Member Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member Chief Operating Officer | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Director of Finance/CFO President Corporate Officer/Principal Chief Tech/Sci/R&D Officer Director/Board Member Corporate Officer/Principal | |
| ENZON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer Chairman Chief Executive Officer Director/Board Member Director/Board Member | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Public Communications Contact General Counsel Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Ludwig-Maximilians-Universität München | College/University | Doctorate Degree Undergraduate Degree Corporate Officer/Principal Graduate Degree | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| VISCOM AG | Industrial Machinery | Founder Founder Director/Board Member Chief Operating Officer | |
| Harvard Medical School | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| ONCOSEC MEDICAL INCORPORATED | Medical/Nursing Services | Chief Executive Officer Chief Executive Officer Director/Board Member Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| Rochester Christian University | College/University | Graduate Degree Masters Business Admin Undergraduate Degree | |
| IDORSIA LTD | Pharmaceuticals: Major | Director/Board Member Chairman General Counsel | |
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| Icahn Capital LP | Investment Trusts/Mutual Funds | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal | |
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Director/Board Member Founder Chairman | |
| BIOGEN INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Vereinte Dienstleistungsgewerkschaft
 Vereinte Dienstleistungsgewerkschaft Miscellaneous Commercial ServicesCommercial Services Vereinte Dienstleistungsgewerkschaft is a trade union based in Germany. The German company provides information on current issues in society, business, politics, culture, and trade union issues through its publication, Ver.di Publik, which appears eight times a year. Ver.di is an expert in good work, fair wages, work-life balance, equal rights, and more. The company takes the time to answer questions and discuss topics in online meetings with its members. Ver.di positions itself with resolutions, declarations, and statements on legislative initiatives and much more. Ver.di TV provides surveys, backgrounds, portraits, reports, and more on the world of work and society. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Idorsia Pharmaceuticals Ltd.
 Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Idorsia Ltd., Idorsia Pharmaceuticals Ltd. is a Swiss company that aims to discover, develop, and provide innovative medicines to patients. The company is based in Allschwil, Switzerland. The company has created an eBook that provides useful information about Fabry disease, a rare inherited disorder caused by the build-up of a fat-like substance in the cells of the body organs. Jean-Paul Clozel has been the CEO of the company since 2017. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
Biogen GmbH
 Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| AVEO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member | |
| CADUS CORPORATION | Biotechnology | Director/Board Member Chief Executive Officer Director/Board Member | |
| University of Freiburg | College/University | Doctorate Degree Doctorate Degree Graduate Degree | |
| STEMLINE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Financial Conglomerates | Consultant / Advisor Corporate Officer/Principal | |
Ortho Biotech Products LP
 Ortho Biotech Products LP Pharmaceuticals: MajorHealth Technology Ortho Biotech Products LP provides innovative products and services which are designed to enhance the lives of individuals with serious chronic illnesses. The company's products include PROCRIT, DOXIL and LEUSTATIN. Ortho Biotech Products was founded in 1990 and is headquartered in Bridgewater, NJ | Pharmaceuticals: Major | President Sales & Marketing | |
Kuur Therapeutics Ltd.
 Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Chairman Chairman | |
| OCERA THERAPEUTICS INC | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer | |
| NPS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | General Counsel General Counsel | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
National Academy of Medicine (United States)
 National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Indianapolis Museum of Art, Inc.
 Indianapolis Museum of Art, Inc. Other Consumer ServicesConsumer Services Indianapolis Museum of Art, Inc. operates an art museum. It features collections of African, Asian, European, and contemporary art, as well as a collection of design arts. The firm offers visitors a view of arts and culture through its collection of a number of works of art that spans thousands of years of history from across the world's continents. Its collections include paintings, sculpture, furniture and design objects, prints, drawings and photographs, as well as textiles and costumes. The company was founded in 1883 and is headquartered in Indianapolis, IN. | Other Consumer Services | Director/Board Member Director/Board Member | |
Molecular Partners, Inc.
 Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| VERASTEM, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| ATON | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
HPC Vermögensverwaltung GmbH
 HPC Vermögensverwaltung GmbH Electronic Equipment/InstrumentsElectronic Technology HPC Vermögensverwaltung GmbH develops, manufactures and sells machines, equipment, components and software for industrial quality assurance. The firm main operating subsidiary, Viscom AG, manufactures inspection systems for the electronics industry. The company is headquartered in Hannover, Germany. | Electronic Equipment/Instruments | Corporate Officer/Principal Director/Board Member | |
| UNIQURE N.V. | Biotechnology | Chairman Chief Executive Officer | |
| Hanover Centre For Optical Technologies | Chairman Director/Board Member | ||
| Massachusetts Institute of Technology | College/University | Undergraduate Degree Undergraduate Degree | |
| CELLECTIS S.A. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer |
Statistics
International
| United States | 31 |
| Germany | 10 |
| Switzerland | 4 |
| Denmark | 3 |
| United Kingdom | 3 |
Sectoral
| Health Technology | 31 |
| Commercial Services | 7 |
| Consumer Services | 7 |
| Finance | 4 |
| Producer Manufacturing | 2 |
Operational
| Director/Board Member | 493 |
| Corporate Officer/Principal | 219 |
| Chairman | 159 |
| Independent Dir/Board Member | 135 |
| Chief Executive Officer | 94 |
Most connected contacts
| Insiders | |
|---|---|
| Carl Icahn | 57 |
| Annalisa Jenkins | 51 |
| John Johnson | 40 |
| Steven Paul | 38 |
| Eric Rowinsky | 36 |
| David Sidransky | 32 |
| Charles Woler | 29 |
| Jules Haimovitz | 27 |
| William Burns | 27 |
| Gino Santini | 26 |
| Alexander Denner | 25 |
| Ferdinand Verdonck | 25 |
| Thomas O. Hecht | 24 |
| Berndt A. E. Modig | 23 |
| Harry Welten | 22 |
- Stock Market
- Insiders
- Andreas Harstrick
- Company connections
